Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells

Clinical Cancer Research

Volumn 15, Issue 15, 2009, Pages 4925-4934

  Lee, Do Hun ^a   Ahn, Yong ^b   Kim, Seung U ^d,e   Wang, Kyu Chang ^a   Cho, Byung Kyu ^a   Ji, Hoon Phi ^a   Park, In Ho ^f   Black, Peter M ^g   Carroll, Rona S ^g   Lee, Joonyub ^c   Kim, Seung Ki ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Gimpo Airport Wooridul Spine Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Chung Ang University College of Medicine   (South Korea)

^f Gachon University   (South Korea)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOSINE DEAMINASE; FLUCYTOSINE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN STEM TUMOR; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENETIC ENGINEERING; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSINE DEAMINASE; FEMALE; GENE THERAPY; GLIOMA; HUMANS; INTERFERON-BETA; MESENCHYMAL STEM CELLS; NEURONS; RATS; STEM CELLS;

EID: 68049129853     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-3076     Document Type: Article

References (39)

1. Albright AL. Diffuse brainstem tumors: when is a biopsy necessary? Pediatr Neurosurg 1996;24: 252-255
2. Epstein F, Wisoff JH. Intrinsic brainstem tumors in childhood: surgical indications. J Neurooncol 1988;6:309-317 (Pubitemid 19032428)
3. Littman P, Jarrett P, Bilaniuk LT, et al. Pediatric brain stem gliomas. Cancer 1980;45:2787-2792
4. Aghi M, Chiocca EA. Gene therapy for glioblastoma. Neurosurg Focus 2006;20:E18.
5. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci 2000;97:12846-12851 (Pubitemid 30840504)
6. Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000;6:447-450 (Pubitemid 30208163)
7. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002;62:5657-5663 (Pubitemid 35204717)
8. Ehtesham M, Kabos P, Gutierrez MA, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002;62:7170-7174 (Pubitemid 36025232)
9. Kim SK, Cargioli TG, Machluf M, et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005;11:5965-5970 (Pubitemid 41170327)
10. Kim SK, Kim SU, Park IH, et al. Human neural stem cells target experimental intracranial medulloblastoma and delivera therapeutic gene leading to tumorr egression. Clin Cancer Res 2006;12:5550-5556
11. Ehtesham M, Stevenson CB, Thompson RC. Stem cell therapies for malignant glioma. Neurosurg Focus 2005;19:E5.
12. Hamada H, Kobune M, Nakamura K, et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005;96:149-156 (Pubitemid 40575915)
13. Lee HJ, Kim KS, Kim EJ, et al. Brain transplantation of human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 2007;25:211-224
14. Mapara KY, Stevenson CB, Thompson RC, Ehtesham M. Stem cells as vehicles forthe treatment of brain cancer. Neurosurg Clin N Am 2007;18:71-80. (Pubitemid 46161190)
15. Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65:3307-3318 (Pubitemid 40524615)
16. Singh G. Sources of neuronal material for implantation. Neuropathology 2001;21:110-114
17. Kabos P, Ehtesham M, Kabosova A, Black KL, Yu JS. Generation of neural progenitor cells from whole adult bone marrow. Exp Neurol 2002;178:288-293 (Pubitemid 36062638)
18. Lee J, Elkahloun AG, Messina SA, et al. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellularvector . Cancer Res 2003;63:8877-8889 (Pubitemid 38064068)
19. Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004;11:1155-1164 (Pubitemid 39117311)
20. Yuan X, Hu J, Belladonna ML, Black KL, Yu JS. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 2006; 66:2630-2638
21. Cho T, Bae JH, Choi HB, et al. Human neural stem cells: electrophysiological properties of voltage-gated ion channels. Neuroreport 2002; 13:1447-1452
22. Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004;24:159-171
23. Kim SU, Nagai A, Nakagawa E, et al. Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol Biol 2008;438:103-121
24. Ourednik V, Ourednik J, Flax JD, et al. Segregation of human neural stem cells in the developing primate forebrain. Science 2001;293:1820-1824 (Pubitemid 32845777)
25. Nagai A, Kim WK, Lee HJ, et al. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE 2007;2:e1272. (Pubitemid 351722479)
26. Lee J, Jallo GI, Guar nieri M, Carson BS, Sr., Penno MB. A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization. Neurosurg Focus 2005;18:E11.
27. Schmidt KF, Ziu M, Schmidt NO, et al. Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. J Neurooncol 2004;68:207-215 (Pubitemid 38878254)
28. Xu F, Zhu JH. Stem cells tropism for malignant gliomas. Neurosci Bull 2007;23:363-369
29. Parker AM, Katz AJ. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 2006;6:567-578 (Pubitemid 43837184)
30. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, AltanerC . Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007;67:6304-6313
31. Black LL, Gaynor J, Gahring D, et al. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 2007;8:272-284
32. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005;13:845-853
33. Winter A, Breit S, Parsch D, et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrowderived and adipose tissue-derived stromal cells. Arthritis Rheum 2003;48:418-429 (Pubitemid 36278011)
34. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, oradipose tissue. Stem Cells 2006;24:1294-1301 (Pubitemid 44464698)
35. Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 2002;14:160-164 (Pubitemid 34235048)
36. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675 (Pubitemid 38268958)
37. Mavr oudis D, Read E, Cottler-Fox M, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants forhe matologic malignancies. Blood 1996;88: 3223-3229
38. Jurvansuu J, Zhao Y, Leung DS, et al. Transmembrane protein 18 enhances the tropism of neural stem cells forg lioma cells. Cancer Res 2008;68:4614-4622
39. Ehtesham M, Yuan X, Kabos P, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004;6:287-293 (Pubitemid 38657085)